The real-world outcomes of multiple myeloma patients treated with daratumumab.

The real-world outcomes of multiple myeloma patients treated with daratumumab.

Most patients cannot be included in randomized clinical trials. We report real-world outcomes of all Danish patients with multiple myeloma (MM) treated with daratumumab-based regimens until 1 January 2019.<h4>Methods</h4>Information of 635 patients treated with daratumumab was collected...

Full description

Saved in:
Bibliographic Details
Main Authors: Agoston Gyula Szabo, Tobias Wirenfeldt Klausen, Mette Bøegh Levring, Birgitte Preiss, Carsten Helleberg, Marie Fredslund Breinholt, Emil Hermansen, Lise Mette Rahbek Gjerdrum, Søren Thorgaard Bønløkke, Katrine Nielsen, Eigil Kjeldsen, Katrine Fladeland Iversen, Elena Manuela Teodorescu, Marveh Dokhi, Eva Kurt, Casper Strandholdt, Mette Klarskov Andersen, Annette Juul Vangsted
Format: article
Language:EN
Published: Public Library of Science (PLoS) 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/3a1957b6a5774014bba30b82888f0eeb
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/3a1957b6a5774014bba30b82888f0eeb

Similar Items